September 17th 2025
The Committee is scheduled to meet on September 18 and 19 to discuss recommendations for several vaccines.
September 16th 2025
Thao-Ly Phan, MD, MPH, highlights how lessons from pandemic-related weight gain can guide pediatricians in addressing stress, prevention, and whole-child health.
September 12th 2025
Children diagnosed with COVID-19 gained more weight than COVID-negative peers, especially after diagnosis, during the pandemic.
September 11th 2025
Capvaxive was superior to PPSV23 for each of the 9 serotypes unique to Capvaxive and non inferior to PPSV23 for the 12 shared serotypes.
September 8th 2025
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
Vimkunya chikungunya vaccine launches for ages 12 years and older
Prior to approval on February 14, 2025, the only FDA approved vaccine for chikungunya protection was indicated for 18 years and up.
Karen Capusan, DNP, CPNP-PC, discusses the current landscape of RSV
Karen Y. Capusan, DNP, CPNP-PC, explored RSV’s shifting epidemiology, seasonal trends, and new vaccines’ role in reducing hospitalizations at the 2025 NAPNAP National Conference.
Measles outbreaks: 223 cases reported in Texas
Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, comments on the ongoing measles outbreaks and encourages advocation for vaccines and accurate information.
2025 immunization update recap with Mary Koslap-Petraco, DNP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP, highlighted key updates on influenza, COVID-19, and RSV vaccines at the 2025 NAPNAP National Conference.
2025 immunization update: addressing vaccine hesitancy and catch-up vaccinations
Mary Koslap-Petraco highlighted the need to address vaccine hesitancy, catch up on immunizations, and build trust with parents at the 2025 NAPNAP National Conference on Pediatric Health Care.
How canceled government agency meetings could impact vaccination schedules, with Mary Koslap-Petraco, DNP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP, reacts to the recent cancelations of the ACIP and VRBPAC and comments on the potential down stream effects.
Weekly review: Roflumilast 0.05% sNDA accepted, palforzia launches for US toddlers
CMV linked to increased necrotizing enterocolitis severity in premature infants
Cytomegalovirus (CMV) may worsen necrotizing enterocolitis (NEC) in premature infants, leading to severe intestinal damage.
Tina Tan, MD, comments on the measles outbreak in Texas, vaccine-preventable diseases
"The measles outbreak that is currently happening in Texas and New Mexico is occurring in an area of the states that have very high anti-vaccine sentiments," Tan said.
Breaking down invasive meningococcal disease vaccines, including Penmenvy
Amin Barakat, MD, FAAP, details meningococcal disease vaccines and highlights the recently FDA-approved MenABCWY vaccine from GSK.
RSV prevention strategies show high uptake, positive outcomes
Study findings underscore the effectiveness of a dual approach to RSV prevention.
Reacting to the meningococcal ABCWY vaccine approval with Donna Hallas, PhD, PPCNP-BC
Nurse practitioner Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN offers her thoughts on the recent FDA approval of GSK's meningococcal ABCWY vaccine.
FDA approves GSK's meningococcal ABCWY vaccine
The combination vaccine targets 5 groups of the bacteria Neisseria meningitidis (A,B,C,W, AND Y) that cause the most invasive meningococcal disease cases (IMD) globally.
Study: Most children recover within 6 months after severe MIS-C following COVID-19 infection
Most children with MIS-C recover within 6 months, with heart function and overall health improving significantly, according to a new study.
Atypical presentations of Mycoplasma pneumoniae amid a local outbreak
M pneumoniae infection is not a reportable disease, and testing is often not performed in the outpatient setting, limiting estimates of clinical prevalence and delaying recognition of community epidemics.
Experts: Now is the time to be the biggest child health care advocate
In this discussion, leading experts weigh in on the importance of scientific integrity, proactive advocacy, and the crucial role of vaccinations in pediatric health.
Weekly review: Changing atopic dermatology treatments, new puzzler, more
Tina Tan, MD, comments on a severe respiratory season, stresses timely vaccination
Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the severity of the current respiratory virus season and stresses the importance of vaccinations to protect against influenza, COVID-19, RSV, and more.
A preview of the January/February 2025 issue of Contemporary Pediatrics
Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the January/February, 2025, issue of Contemporary Pediatrics.
Tina Tan, MD discusses the increased outbreaks of norovirus this year
Based on recent reports, norovirus outbreaks in the 2024-2025 seasonal year is above the range reported from the 2012-2020 and 2021-2024 seasonal years.
AAP: These tips can keep kids comfortable amid cold & flu season
During the current cold and flu season, children have a higher risk of getting sick. The AAP has release tips and reminders for parents to help keep children comfortable and healthy.
Discussing pediatric vaccination with vaccine-hesitant parents
Robert Frenck, MD, offers several practical tips to use when discussing pediatric vaccination among vaccine-hesitant parents.
Despite decreases of invalid vaccine doses, series completion still lacks
Of those with a minimum age or minimum interval vaccine dose, 44.9% ended up receiving extra doses to complete a vaccination series.
Weekly review: New peanut patch data, norovirus outbreaks, and more
CDC: 2024-2025 seasonal norovirus outbreaks up from previous years
Based on reports by NoroSTAT-participating states, the total number of outbreaks in 2024-2025 seasonal year is above the range reported 012–2020 and 2021-2024 seasonal years.
Study: Nearly 80% of infants born in 2023-24 RSV season received RSV protection
The study within a single health care system revealed that most infants born prior to December received the nirsevimab monoclonal antibody.
Robert Frenk, MD: 2024 was big year for RSV prevention
Robert Frenck, MD, explained why 2024 was a big step in the right direction for RSV prevention, and emphasized the importance of vaccination against preventable diseases.
COVID-19 Roundtable: Prophylaxis for the immunocompromised
This week the panel weighs in on monoclonal antibodies in this patient population as well as important overall takeaways about COVID-19 therapies.
COVID-19 Roundtable: Considering off label therapies
This week, our experts weigh in on treatments not specifically indicated for COVID-19 treatment, including metformin, and concerns around using medications in this way.
Contemporary Pediatrics’ top 3 FDA approvals of 2024
From new topical dermatology treatments for atopic dermatitis to the first nasal spray to treat type 1 allergic reactions, these are our top FDA approvals of 2024.